Exosomes vs. PRP: What’s the Difference?

Platelet-rich plasma (PRP) is made from your own blood during the visit. Exosomes are tiny vesicles collected from donor cells grown in a laboratory, then sold as a manufactured product. PRP is prepared with FDA-cleared devices and used off-label, while no exosome product is FDA-approved for any use (Beitzel et al., 2015; U.S. Food and Drug Administration [FDA], 2019). In the only published head-to-head skin trial, both produced similar improvement, but that trial had 15 participants (Estupiñan et al., 2025).

What This Means

PRP starts with a small blood draw. A centrifuge separates the blood, and the platelet-rich layer is collected. Platelets carry growth factors, such as PDGF, VEGF and TGF-β, that take part in normal tissue repair (Estupiñan et al., 2025). Because the material comes from you, there is no donor and no outside manufacturing.

Exosomes are extracellular vesicles, bubbles far smaller than a cell, that cells release to send proteins and genetic messages such as microRNA to neighboring cells. Commercial exosome products are usually harvested from donor cells, often mesenchymal stem cells from fat or birth tissue, grown in a lab (Estupiñan et al., 2025). That means purity, dose and content depend on the manufacturer.

The regulatory difference matters. FDA regulates the machines and kits used to make PRP as medical devices; the clearance covers how the device concentrates platelets, not a specific clinical use (Beitzel et al., 2015). Exosome products, by contrast, are regulated as drugs and biological products, which require FDA approval before they can be legally marketed for a medical use, and none has that approval (FDA, 2019).

Candidacy

People ask about both options mostly for three goals: skin quality, thinning hair, and joint or tendon pain. The research on each goal is different, so candidacy depends on which goal you have and what has already been tried.

PRP needs a blood draw, so people with certain blood or platelet disorders, active infection at the site, or some cancers are generally not candidates. Exosome products skip the blood draw, which some needle-averse patients prefer, but they introduce donor-derived material and manufacturing variables (Estupiñan et al., 2025). Pregnancy, uncontrolled medical conditions and unrealistic expectations are reasons to pause on either. A licensed physician decides candidacy after an evaluation.

Clinical Evaluation

At PrimeCell Regenerative, I start with your history, medications, and what you hope to change. For hair, that means looking at the pattern and timeline of shedding and checking for thyroid, iron or hormone contributors. For skin, it means sun history, skin type and prior procedures. For a painful joint or tendon, it means an exam and, when useful, ultrasound. The goal is to identify what is driving the problem before choosing any biologic.

Available Options

Mainstream options come first and often work well on their own. For pattern hair loss, topical minoxidil remains the most accessible choice, though it has to be used continuously to keep results (Darwish et al., 2025). Oral prescription medications may also be discussed. For sun-damaged skin, daily sunscreen, prescription retinoids, lasers and microneedling are established approaches. For joint and tendon pain, exercise-based rehabilitation comes first.

After those, PRP is an option many practices offer, including PrimeCell. Exosome products are investigational and, at PrimeCell, are discussed only for selected patients with written informed consent. For skin, both are most often applied topically right after microneedling, when small channels in the skin allow them to reach deeper layers. For a comparison of PRP with cell-based injections, see PRP vs. stem cell therapy.

Benefits, Limitations and Risks

PRP. The possible benefits come from your own concentrated platelets, and there is no risk of receiving donor material. Its limitations include variation between preparation systems, the need for a blood draw, and results that differ from person to person. Common effects include soreness, bruising and swelling at the site.

Exosomes. Exosome products are ready to use and need no blood draw. Their limitations are larger: products vary by manufacturer, dosing is not standardized, and long-term human safety data are thin. FDA has warned about serious adverse events, including in patients in Nebraska who received unapproved products marketed as containing exosomes (FDA, 2019). FDA has also warned that unapproved regenerative products can cause infections and other serious harm (FDA, 2024). Published reports of problems after exosome injection include granulomas, loss of blood supply to the skin, tissue death, allergic reactions and severe infections (Estupiñan et al., 2025). Topical use after microneedling has had a better early safety record than injection, but that record comes from small studies.

What the Evidence Shows

What it does establish. In a 2025 split-face trial, 15 adults with sun-damaged skin had three radiofrequency microneedling sessions, with PRP applied to one side of the face and adipose-derived exosomes to the other. Both sides improved in wrinkling, pigment, redness and texture at 3 and 6 months, and biopsies showed more type I collagen on both sides, with no significant difference between them. No adverse events were reported (Estupiñan et al., 2025). A 2025 systematic review of pattern hair loss concluded that exosomes looked most promising for regrowth and safety, followed by PRP, with minoxidil the most accessible option (Darwish et al., 2025).

What it does not establish. The split-face trial was small, not randomized, and did not run statistical tests on the clinical scores because of its size; the authors called for larger trials (Estupiñan et al., 2025). The hair-loss review also called for further research before its findings guide clinical decisions (Darwish et al., 2025). No trial has shown that one product is better than the other for every goal, and results from a topical skin study do not carry over to injections in joints or the scalp. FDA has not approved any exosome product (FDA, 2019).

Recovery and Next Steps

After a skin session with either product, redness, mild swelling and light crusting usually settle within a week (Estupiñan et al., 2025). Studies judge results over months, and most skin and hair protocols involve a series of sessions. Protect the skin from the sun and follow the aftercare plan you are given.

Before choosing, ask which product will be used, where it comes from, what its FDA status is, whether it will be applied or injected, and how progress will be measured.

Orlando Considerations

PrimeCell is a self-pay practice. PRP and exosome procedures are generally not covered by insurance, and any plan is quoted in a written estimate after the evaluation. Qualifying patients can use Cherry payment plans. For how costs are set, see Cost & written estimates.